Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Revenue (2017 - 2025)

Historic Revenue for Lexaria Bioscience (LEXX) over the last 12 years, with Q3 2025 value amounting to $174000.0.

  • Lexaria Bioscience's Revenue rose 10714.29% to $174000.0 in Q3 2025 from the same period last year, while for Nov 2025 it was $522000.0, marking a year-over-year increase of 504.65%. This contributed to the annual value of $705923.0 for FY2025, which is 5204.75% up from last year.
  • As of Q3 2025, Lexaria Bioscience's Revenue stood at $174000.0, which was up 10714.29% from $174000.0 recorded in Q2 2025.
  • Lexaria Bioscience's 5-year Revenue high stood at $6.3 million for Q3 2021, and its period low was $13880.0 during Q4 2021.
  • Moreover, its 5-year median value for Revenue was $111150.0 (2022), whereas its average is $439797.4.
  • Its Revenue has fluctuated over the past 5 years, first surged by 461686.12% in 2021, then plummeted by 9823.8% in 2022.
  • Lexaria Bioscience's Revenue (Quarter) stood at $13880.0 in 2021, then soared by 604.14% to $97735.0 in 2022, then soared by 54.78% to $151278.0 in 2023, then grew by 21.58% to $183923.0 in 2024, then fell by 5.4% to $174000.0 in 2025.
  • Its Revenue stands at $174000.0 for Q3 2025, versus $174000.0 for Q2 2025 and $174000.0 for Q1 2025.